Indinavir: A rare urinary stone in HIV-1-infected patients - Occurrence and crystal properties

被引：0
|
作者：
Tessadri, R [1 ]
Griesser, UJ
Prillinger, M
Wurst, K
机构：
[1] Univ Innsbruck, Inst Mineral & Petrog, A-6020 Innsbruck, Austria
[2] Univ Innsbruck, Inst Pharm, A-6020 Innsbruck, Austria
[3] Univ Innsbruck, Inst Gen Inorgan & Theoret Chem, A-6020 Innsbruck, Austria
来源：
EUROPEAN POWDER DIFFRACTION EPDIC 8 | 2004年 / 443-4卷
关键词：
crystal properties; crystal structure; indinavir; indinavir sulphate; urinary stones;
D O I：
10.4028/www.scientific.net/MSF.443-444.407
中图分类号：
O7 [晶体学];
学科分类号：
0702 ; 070205 ; 0703 ; 080501 ;
摘要：
引用
收藏
页码：407 / 410
页数：4
相关论文
共 50 条
  • [41] PREDICTION OF CEREBRAL TOXOPLASMOSIS IN HIV-1-INFECTED PATIENTS
    SCHAUB, R
    ROLFS, A
    NEUROLOGY, 1994, 44 (04) : A250 - A250
  • [42] Pharmacokinetics of reduced-dose indinavir/ritonavir 400/100 mg twice daily in HIV-1-infected Thai patients
    Boyd, M
    Mootsikapun, P
    Burger, D
    Chuenyam, T
    Ubolyam, S
    Mahanontharit, A
    Sangkote, J
    Bunyaprawit, P
    Horsakulchai, M
    Lange, J
    Cooper, D
    Phanuphak, P
    Ruxrungtham, K
    ANTIVIRAL THERAPY, 2005, 10 (02) : 301 - 307
  • [43] DISTRIBUTION OF INTESTINAL LYMPHOCYTE-T SUBSETS IN DIFFERENT BOWEL COMPARTMENTS OF HIV-1-INFECTED AND NOT HIV-1-INFECTED PATIENTS
    FRANZEN, C
    SALZBERGER, B
    FATKENHEUER, G
    EIDT, S
    SCHRAPPE, M
    MEDIZINISCHE KLINIK, 1992, 87 (10) : 510 - &
  • [44] Urinary stones in HIV-1-positive patients treated with indinavir
    Daudon, M
    Estepa, L
    Viard, JP
    Joly, D
    Jungers, P
    LANCET, 1997, 349 (9061): : 1294 - 1295
  • [45] Pharmacokinetics of indinavir/ritonavir (800/100 mg) in combination with efavirenz (600 mg) in HIV-1-infected subjects
    Boyd, MA
    Aarnoutse, RE
    Ruxrungtham, K
    Stek, M
    van Heeswijk, RPG
    Lange, JMA
    Cooper, DA
    Phanuphak, P
    Burger, DM
    JAIDS-JOURNAL OF ACQUIRED IMMUNE DEFICIENCY SYNDROMES, 2003, 34 (02) : 134 - 139
  • [46] DETERMINATION OF ANTICARDIOLIPIN AND OTHER ANTIBODIES IN HIV-1-INFECTED PATIENTS
    BERNARD, C
    EXQUIS, B
    REBER, G
    DEMOERLOOSE, P
    JOURNAL OF ACQUIRED IMMUNE DEFICIENCY SYNDROMES, 1990, 3 (05) : 536 - 539
  • [47] INCREASED RECURRENCE OF TUBERCULOSIS IN HIV-1-INFECTED PATIENTS IN KENYA
    HAWKEN, M
    NUNN, P
    GATHUA, S
    BRINDLE, R
    GODFREYFAUSSETT, P
    GITHUI, W
    ODHIAMBO, J
    BATCHELOR, B
    GILKS, C
    MORRIS, J
    MCADAM, K
    LANCET, 1993, 342 (8867): : 332 - 337
  • [48] Hyperglycemia associated with protease inhibitors in HIV-1-infected patients
    Gómez-Vera, J
    de Alarcón, A
    Jiménez-Mejías, ME
    Acosta, D
    Prados, D
    Viciana, P
    CLINICAL MICROBIOLOGY AND INFECTION, 2000, 6 (07) : 391 - 394
  • [49] Impact of lipodystrophy on the quality of life of HIV-1-infected patients
    Blanch, J
    Rousaud, A
    Martínez, E
    De Lazzari, E
    Peri, JM
    Milinkovic, A
    Perez-Cuevas, TB
    Blanco, TL
    Gatell, JM
    JAIDS-JOURNAL OF ACQUIRED IMMUNE DEFICIENCY SYNDROMES, 2002, 31 (04) : 404 - 407
  • [50] Associative and predictive biomarkers of dementia in HIV-1-infected patients
    Bandaru, V. V. R.
    McArthur, J. C.
    Sacktor, N.
    Cutler, R. G.
    Knapp, E. L.
    Mattson, M. P.
    Haughey, N. J.
    NEUROLOGY, 2007, 68 (18) : 1481 - 1487
12345